Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Rob Jones

- PMLiVE

Takeda offers €520m for stem cell firm TiGenix

The deal will go ahead if the Japanese pharma company can secure an 85% stake in the biotech

- PMLiVE

Novartis’ Promacta receives US breakthrough therapy designation

Regulatory filings of the rare blood disorder treatment are expected this year

- PMLiVE

INC Research/InVentiv Health becomes Syneos Health

Renamed company will focus on biopharmaceutical solutions

- PMLiVE

Mundipharma appoints chief information officer

Philippe Mazas joins the UK-based pharma network from Smith & Nephew

MedTech Europe appoints new board of directors

Chair of the board Michelle Brennan is among those newly elected

- PMLiVE

Huntsworth reshuffle sees Nitrogen and Tonic join its Evoke Group

The agencies will continue under current leaders Jon Clark and Maryellen Royle

- PMLiVE

BIA launches R&D communications best practice guide

Aims to support UK bioscience groups interacting with investors and the public

- PMLiVE

Seattle Genetics’ Adcetris earns FDA priority review status

The win follows a breakthrough designation from the US regulator last year

- PMLiVE

NICE backs GSK’s €594k gene therapy for rare disease

The treatment offers 'bubble baby' patients an alternative to a stem cell transplant

- PMLiVE

Spark sets Luxturna price, igniting US affordability debate

The IRD treatment is set to cost patients $425,000 per eye

Sharp rise in mobile health app numbers

US app stores show more than 318,500 now available

- PMLiVE

Makara Health appoints Louise Finke as a director

She will support the healthcare comms agency’s strategic programme delivery

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links